Metabolic syndrome laboratory findings

Jump to navigation Jump to search

Metabolic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Metabolic Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Dietary Therapy

Physical Activity

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Metabolic syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Metabolic syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Metabolic syndrome laboratory findings

CDC on Metabolic syndrome laboratory findings

Metabolic syndrome laboratory findings in the news

Blogs on Metabolic syndrome laboratory findings

Directions to Hospitals Treating Metabolic syndrome

Risk calculators and risk factors for Metabolic syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, M.B.B.S. [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

The diagnosis of metabolic syndrome is mostly based on physical examination and lab tests. The diagnostic criteria of different international societies also involves consideration of lab tests like lipid profile and fasting blood glucose.

Laboratory Findings

Metabolic syndrome is a proinflammatory and prothrombotic state. Additional biomarkers that are worth measuring while evaluating metabolic syndrome include:

Studies have shown that elevated levels of these proinflammatory and prothrombotic biomarkers are associated with an increased risk for coronary artery disease (CAD) and type II diabetes. Hence measurement of these markers should be considered in the setting of CAD risk assessment.

If PCOS is suspected the following lab tests should be included in the management of metabolic syndrome:

References

  1. 1.0 1.1 Huang PL (2009). "A comprehensive definition for metabolic syndrome". 2 (5–6): 231–7. doi:10.1242/dmm.001180. PMC 2675814.

Template:WS Template:WH